OBJECTIVES.: The purpose of this study is to determine the impact of the Bethesda System
2001 recommendation of reporting cytologically benign appearing endometrial cells (BEC) …

Abstract BACKGROUND The 2001 Bethesda System recommends reporting benign
endometrial cells (BECs) in women aged≥ 40 years and considers these women at risk for …

Abstract The 2001 Bethesda System revision recommends reporting benign-appearing
endometrial cells (BAEMC) in all women 40 years or older, not just in postmenopausal …

Abstract BACKGROUND The 2001 Bethesda System (TBS 2001) introduced a new
diagnostic category—normal endometrial cells in women age 40 years or older (EM≥ 40) …

Objective: The 2014 Bethesda System recommends that benign-appearing endometrial
cells (BECs) in routine Pap tests should be reported in patients aged≥ 45 years. This is a …

Abstract Objective: The Bethesda System 2001 for reporting cervical cytology recommends
reporting benign-appearing, exfoliated endometrial cells in women aged 40 years or older …

Goals This study aims to examine the effects of raising the reporting age for benign
endometrial cells (BEC) on Papanicolaou (Pap) tests according to the 2014 3rd edition of …

Background: The 2014 Bethesda System recommends reporting the finding of benign-
appearing, exfoliated endometrial cells on Papanicolaou (Pap) tests in women aged 45 …

Objectives Reporting benign-appearing endometrial cells (nEMCs) in Papanicolaou (Pap)
smears of women 40 years and older, introduced in The Bethesda System 2001, may be …

Abstract Objectives The 2014 Bethesda System (TBS 2014) guidelines for reporting cervical
cytology revised the age for reporting benign endometrial cells (BECs) from 40 years or …